Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000807009 | SCV000947034 | uncertain significance | Arginine:glycine amidinotransferase deficiency | 2022-08-20 | criteria provided, single submitter | clinical testing | This sequence change replaces lysine, which is basic and polar, with asparagine, which is neutral and polar, at codon 201 of the GATM protein (p.Lys201Asn). This variant is present in population databases (rs748600834, gnomAD 0.006%). This variant has not been reported in the literature in individuals affected with GATM-related conditions. ClinVar contains an entry for this variant (Variation ID: 651610). Algorithms developed to predict the effect of missense changes on protein structure and function are either unavailable or do not agree on the potential impact of this missense change (SIFT: "Deleterious"; PolyPhen-2: "Benign"; Align-GVGD: "Class C0"). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |
Gene |
RCV001562106 | SCV001784823 | uncertain significance | not provided | 2023-06-27 | criteria provided, single submitter | clinical testing | Reported in a patient with hypomyelinating leukodystrophy type 2 in the published literature who also had a variant in another gene that may have been responsible for the phenotype (Komachali et al., 2022); Not observed at a significant frequency in large population cohorts (gnomAD); In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; This variant is associated with the following publications: (PMID: 35794704) |
Fulgent Genetics, |
RCV002501087 | SCV002813446 | uncertain significance | Arginine:glycine amidinotransferase deficiency; Fanconi renotubular syndrome 1 | 2021-11-17 | criteria provided, single submitter | clinical testing |